Medication AdherenceNCT07751627
System Usability of the MedTracks App to Aid Medication Adherence
A study testing Testing of digital application in people with Medication Adherence, run by NHS Highland Research, Development and Innovation Organisation at 1 site in United Kingdom.
Trial summary
This project aims to examine whether the MedTracks app is useful and easy to use for a cohort of adults taking two or more oral medications. It will also aim to indicate if use of the app changes attitudes and improves self-reported medication adherence. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Medication Adherence
- What is being tested?
- Testing of digital application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 3 Dec 2024to 31 Mar 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- NHS Highland registered patient
- Adults aged 40 and above
- Able to understand the Participant Information Sheet, able to provide written informed consent electronically and complete self-reporting eligibility questionnaire
- Volunteers who take 2 or more different prescription oral medications
- Owning a compatible smartphone (device with Android 8.0 or higher (mid
- 2017) or alternatively iPhone with iOS 12.0 or higher (mid 2018). 6) Willing for the MedTracks app to be 'active' on the smartphone device for the duration of the Test Phase, including active reliable internet connection.
Who cannot join
- Non-NHS Highland patient
- Age <40
- Unable to provide written informed consent electronically or not able to understand the Participant Information Sheet
- Currently using an existing app to help with remembering to take their medication
- Vulnerable people deemed inappropriate to approach e.g. prisoners
- Not owning* a smartphone suitable for accessing the app (*for purposes of the study "own" means to consider the device to be their own personal item that they access independently)
- Currently taking part in an interventional trial if being in another study is an exclusion criteria for the other study.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Clinical Research Facility, RD&I Division, UHI House, Old Perth Road, Inverness IV2 3JH
Inverness, Highlands, IV2 3JH
About this study
This project aims to examine whether the MedTracks app is useful and easy to use for a cohort of adults taking two or more oral medications. It will also aim to indicate if use of the app changes attitudes and improves self-reported medication adherence. Qualitative interviews will be conducted with a sub-set of participants to examine issues in greater depth.
Read the detailed description
Medication adherence in chronic disease remains a significant global challenge, contributing to poorer health outcomes and increased healthcare costs. Although efforts have been made to improve adherence, non-adherence continues to be a major issue, particularly for people managing long-term conditions rather than short-term illnesses.
Research suggests that improving medication adherence can have substantial benefits, but there is no single solution that completely resolves the problem. Reasons for non-adherence can be broadly divided into intentional and unintentional factors. One of the most common unintentional reasons is simply forgetting to take medication, highlighting the potential value of reminder-based interventions.
While face-to-face approaches have been effective in improving adherence, digital technologies are increasingly being explored as accessible and scalable alternatives. Smartphone ownership is now widespread, providing opportunities for mobile health applications that support medication management. Evidence indicates that electronic reminders, including text messages and app-based notifications, can improve adherence and are often associated with high levels of user satisfaction.
Developing long-term medication-taking habits is an important aspect of adherence, and personalised approaches may be particularly effective. Technology can help support these approaches by tailoring reminders and routines to individual users. Research into music and memory suggests that music can have a strong and lasting connection to memory, even in people experiencing cognitive decline.
The MedTracks app aims to use this principle by incorporating user-selected music into medication reminders. By using music that has personal significance for each individual, the app seeks to create a more engaging and memorable reminder system. This study therefore aims to evaluate the usability and usefulness of the MedTracks app and assess whether it can improve self-reported medication adherence. Given the ongoing challenges associated with medication adherence, evaluating innovative technological solutions such as MedTracks remains an important area of research.
- Conditions
- Medication Adherence
- Being tested
- Testing of digital application
- Keywords
- music, memory, oral medications, MedTracks app
- Medical subject headings
- Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Testing of digital applicationOther
Testing of the MedTracks digital application
| Study group | Role | What they receive |
|---|---|---|
| Testing of digital application | Other | Testing of the MedTracks digital application Receives: Other: Testing of digital application |
What is being measured
The primary outcome is the main question the study is designed to answer.
System Usability Scale (SUS) self-reported questionnaire. A questionnaire to appraise hardware and software. The score is between 0 to 100 with a score of >68 being above average and <68 worse than average. A higher score means better usability.
Measured: At 28 days post consent
Secondary outcomes (2)
Medication Adherence Report Score (MARS-10) validated questionnaire. Scores range from 10 to 50, with a higher score indicating better adherence to medication.
Measured: At consent and at 28 days post consent.
Assess user experience and attitudes to MedTracks App use by means of semi-structured qualitative interviews
Measured: Up to 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2026
- Study start3 Dec 2024
- Primary completion31 Mar 2025
- Study completion31 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medication AdherenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- NHS Highland Research, Development and Innovation Organisation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07751627
- Sponsor's protocol ID
- Highland 1961
- Other IDs
- 347639, 24/YH/0210
- Status last verified
- Aug 2026
- First submitted
- 23 Jun 2026
- Last updated
- 7 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- System Usability of the MedTracks App to Aid Medication Adherence
- ClinicalTrials.gov ID
- NCT07751627
- Acronym / sponsor ID
- Highland 1961
- Conditions
- Medication Adherence
- Keywords
- music, memory, oral medications, MedTracks app
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- NHS Highland Research, Development and Innovation OrganisationUniversity, hospital or other
- Study start
- 3 Dec 2024 (actual)
- Primary completion
- 31 Mar 2025 (actual)
- Study completion
- 31 Mar 2025 (actual)
- First posted
- 7 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project aims to examine whether the MedTracks app is useful and easy to use for a cohort of adults taking two or more oral medications. It will also aim to indicate if use of the app changes attitudes and improves self-reported medication adherence. Qualitative interviews will be conducted with a sub-set of participants to examine issues in greater depth.
Detailed description
Medication adherence in chronic disease remains a significant global challenge, contributing to poorer health outcomes and increased healthcare costs. Although efforts have been made to improve adherence, non-adherence continues to be a major issue, particularly for people managing long-term conditions rather than short-term illnesses.
Research suggests that improving medication adherence can have substantial benefits, but there is no single solution that completely resolves the problem. Reasons for non-adherence can be broadly divided into intentional and unintentional factors. One of the most common unintentional reasons is simply forgetting to take medication, highlighting the potential value of reminder-based interventions.
While face-to-face approaches have been effective in improving adherence, digital technologies are increasingly being explored as accessible and scalable alternatives. Smartphone ownership is now widespread, providing opportunities for mobile health applications that support medication management. Evidence indicates that electronic reminders, including text messages and app-based notifications, can improve adherence and are often associated with high levels of user satisfaction.
Developing long-term medication-taking habits is an important aspect of adherence, and personalised approaches may be particularly effective. Technology can help support these approaches by tailoring reminders and routines to individual users. Research into music and memory suggests that music can have a strong and lasting connection to memory, even in people experiencing cognitive decline.
The MedTracks app aims to use this principle by incorporating user-selected music into medication reminders. By using music that has personal significance for each individual, the app seeks to create a more engaging and memorable reminder system. This study therefore aims to evaluate the usability and usefulness of the MedTracks app and assess whether it can improve self-reported medication adherence. Given the ongoing challenges associated with medication adherence, evaluating innovative technological solutions such as MedTracks remains an important area of research.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Testing of digital application | Other | Other: Testing of digital applicationTesting of the MedTracks digital application |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- NHS Highland registered patient
- Adults aged 40 and above
- Able to understand the Participant Information Sheet, able to provide written informed consent electronically and complete self-reporting eligibility questionnaire
- Volunteers who take 2 or more different prescription oral medications
- Owning a compatible smartphone (device with Android 8.0 or higher (mid
Key exclusion criteria (7 listed)
- Non-NHS Highland patient
- Age <40
- Unable to provide written informed consent electronically or not able to understand the Participant Information Sheet
- Currently using an existing app to help with remembering to take their medication
- Vulnerable people deemed inappropriate to approach e.g. prisoners
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Testing of digital applicationTesting of the MedTracks digital application | Other | Testing of digital application |
Primary outcome
System Usability Scale (SUS) self-reported questionnaire. A questionnaire to appraise hardware and software. The score is between 0 to 100 with a score of >68 being above average and <68 worse than average. A higher score means better usability.
Time frame: At 28 days post consent
2 secondary outcomes
Medication Adherence Report Score (MARS-10) validated questionnaire. Scores range from 10 to 50, with a higher score indicating better adherence to medication.
Time frame: At consent and at 28 days post consent.
Assess user experience and attitudes to MedTracks App use by means of semi-structured qualitative interviews
Time frame: Up to 4 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Medication Adherence
Not yet recruiting
Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition
Hypertension, Diabetes Mellitus, Type 2
Not yet recruiting
A Nurse-Led Personalized Self-Management Counseling Intervention to Improve Medication Adherence and Glycemic Control in Adults With Type 2 Diabetes: A Randomized Controlled Trial
Medication Adherence, Glycemic Control for Diabetes Mellitus
Not yet recruiting
Assessing Psoriasis Treatment Outcomes
Psoriasis
Active, not recruiting
HERDA: Pharmacist-Led Culturally Adapted Intervention for Depression Medication Adherence
Depression
Not yet recruiting
Asthma Ctrl SMART Trial
Asthma in Children, Asthma Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Testing of digital application in people with Medication Adherence, run by NHS Highland Research, Development and Innovation Organisation at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
System Usability Scale (SUS) self-reported questionnaire. A questionnaire to appraise hardware and software. The score is between 0 to 100 with a score of >68 being above average and <68 worse than average. A higher score means better usability. (time frame: At 28 days post consent). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026.